Deciphera
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
200 Smith St, Waltham, Massachusetts, 02...Phone Number
(781) 209-6400Website
www.deciphera.comRevenue
$174.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
5
1
1
1
1
About Deciphera
Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera's FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK is also approved for fourth-line GIST in Australia, Canada, China, and Hong Kong.Explore more
Deciphera Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Deciphera your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Deciphera is spiking on competitors!
Deciphera, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Deciphera had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Deciphera has new funding data
Congratulate Masked Content for being promoted to Masked Content at Deciphera
Product Launch: Get notified when Deciphera launches new products
Website visits: Recent activity has been detected on your website
Check if Deciphera has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Deciphera recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Deciphera as Masked Content
Find 2 more new buyers
Compare Similar Companies to Deciphera
Compare insights from companies similar to Deciphera, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Deciphera is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Deciphera is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Deciphera.
Deciphera financials insights
Gather financial insights about Deciphera, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series B
$90M
2017
Series C
$52M
Stock Offering
$127.5M
2019
Stock Offering
$400M
2020
Stock Offering
$175M
2022
Stock Offering
$150M
Deciphera Tech Stack
A closer look at the technologies used by Deciphera
See more technologies
Most Recent Scoops
Hiring Plans
Deciphera has more open roles in Information Technology than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Deciphera has more open roles in Legal than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Deciphera has more open roles in Sales than it has had at any time in the past 12 months.
Hiring Plans
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Deciphera News & Media
The End Brain Cancer Initiative is Hosting a Free Webinar Featuring the Latest Advances in PCNSL Treatment on March 27
Join the “New Developments in PCNSL Treatment” webinar to learn about new research, clinical trials, specialists, treatments, diagnostics, and support. REDMOND, WA, UNITED STATES, March 23, 2026 /EINPresswire.com/ -- On Friday, March 27th at 11 AM …Registration Open for the New Developments in PCNSL Treatment Webinar Hosted by the End Brain Cancer Initiative
Registration is now open for the “New Developments in PCNSL Treatment” online educational event on March 27th, 2026, hosted by the End Brain Cancer Initiative. REDMOND, WA, UNITED STATES, February 5, 2026 /EINPresswire.com/ -- Registration is now open …Deciphera Announces the Opening of a New Office in Zug, Switzerland - Yahoo Finance
OSAKA, Japan & WALTHAM, Mass., November 17, 2025--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono"), today announced the opening of a new 733-square-meter office in Zug, Switzerland, to accommodate the company’s growth in Europe and partner markets. The occasion will be commemorated with a ceremony attended by company management, including the CEO of Ono, Gyo Sagara, President and CEO of Deciphera, Ryota Udagawa, and regional government officials,
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Deciphera
Sign Up For FreeTo access detailed company insights
Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advan... Read More
